Cargando…
Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study
An increasing number of patients with cancer are being treated with immune checkpoint inhibitors. Consequently, the incidence of immune checkpoint inhibitor-related myocarditis has been increasing. Nonetheless, the diagnostic criteria for the immune checkpoint inhibitor-related myocarditis have not...
Autores principales: | Nishikawa, Tatsuya, Inoue, Takako, Otsuka, Tomoyuki, Kuno, Ikumi, Kukita, Yoji, Nakamura, Harumi, Ikeda, Yoshihiko, Yasui, Taku, Shioyama, Wataru, Oka, Toru, Honma, Keiichirou, Hatakeyama, Kinta, Miyata, Hiroshi, Isei, Taiki, Ishihara, Ryu, Kumagai, Toru, Nishimura, Kazuo, Fujita, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665386/ https://www.ncbi.nlm.nih.gov/pubmed/36378654 http://dx.doi.org/10.1371/journal.pone.0275865 |
Ejemplares similares
-
A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related Myocarditis
por: Nishikawa, Tatsuya, et al.
Publicado: (2022) -
Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis
por: Nishikawa, Tatsuya, et al.
Publicado: (2022) -
Single-drug approach with rivaroxaban: A case of successful anticoagulation against cancer-associated thrombosis
por: Shioyama, Wataru, et al.
Publicado: (2019) -
Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy
por: Nishikawa, Tatsuya, et al.
Publicado: (2023) -
Coronary spastic angina in a multiple myeloma patient treated with bortezomib, lenalidomide, and dexamethasone
por: Yasui, Taku, et al.
Publicado: (2020)